Global Health Limited (MEDANTA) Share Analysis
NSE · Healthcare · Healthcare
Global Health Limited (NSE: MEDANTA) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹1,454.00, P/E 60.4, ROE 15.2%.
Get the AI verdict on MEDANTA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
MEDANTA chart with trendlines
Is MEDANTA a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Global Health Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
MEDANTA key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,454.00 |
| Market cap | ₹39,095 Cr |
| P/E ratio | 60.4 |
| P/B ratio | 9.03 |
| EPS | ₹23.01 |
| Book value per share | ₹161.00 |
| Dividend yield | 0.03% |
| 52-week range | |
| 52-week high | ₹1,544.00 |
| 52-week low | ₹956.00 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 33% |
| FIIs | 9.92% |
| DIIs | 17.01% |
| Public | 39.96% |
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.